{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:44Z","timestamp":1790813984968,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ckj\/sfx146","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T12:33:39Z","timestamp":1512477219000},"page":"191-197","source":"Crossref","is-referenced-by-count":63,"title":["Porphyria and kidney diseases"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-3596","authenticated-orcid":false,"given":"Nicolas","family":"Pallet","sequence":"first","affiliation":[{"name":"INSERM U1147, Centre Universitaire des Saints P\u00e8res, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"},{"name":"Service de N\u00e9phrologie, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"},{"name":"Service de Biochimie, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[{"name":"INSERM U1147, Centre Universitaire des Saints P\u00e8res, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"},{"name":"Service de N\u00e9phrologie, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[{"name":"INSERM U1147, Centre Universitaire des Saints P\u00e8res, Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"},{"name":"Service de N\u00e9phrologie, H\u00f4pital Europ\u00e9en Georges Pompidou, Assistance Publique-H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gouya","sequence":"additional","affiliation":[{"name":"Centre Francais des Porphyries, H\u00f4pital Louis Mourier, Assistance Publique-H\u00f4pitaux de Paris, Colombes, France"},{"name":"INSERM U1149, CNRS ERL 8252, Centre de Recherche sur l\u2019inflammation, Universit\u00e9 Paris Diderot, Site Bichat, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"Laboratory of Excellence, GR-Ex, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoubida","family":"Karim","sequence":"additional","affiliation":[{"name":"INSERM U1149, CNRS ERL 8252, Centre de Recherche sur l\u2019inflammation, Universit\u00e9 Paris Diderot, Site Bichat, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"Laboratory of Excellence, GR-Ex, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Puy","sequence":"additional","affiliation":[{"name":"Centre Francais des Porphyries, H\u00f4pital Louis Mourier, Assistance Publique-H\u00f4pitaux de Paris, Colombes, France"},{"name":"INSERM U1149, CNRS ERL 8252, Centre de Recherche sur l\u2019inflammation, Universit\u00e9 Paris Diderot, Site Bichat, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"Laboratory of Excellence, GR-Ex, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"key\n\t\t\t\t20180626045844_sfx146-B1","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.2016080918","article-title":"A variant of peptide transporter 2 predicts the severity of porphyria-associated kidney disease","volume":"28","author":"Tchernitchko","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B2","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1021\/cr400415k","article-title":"Heme enzyme structure and function","volume":"114","author":"Poulos","year":"2014","journal-title":"Chem Rev"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B3","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MOH.0000000000000330","article-title":"Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments","volume":"24","author":"Manceau","year":"2017","journal-title":"Curr Opin Hematol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.17219\/acem\/58955","article-title":"Clinical, biochemical and molecular characteristics of the main types of porphyria","volume":"25","author":"Szlendak","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1056\/NEJMra1608634","article-title":"Porphyria","volume":"377","author":"Bissell","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","article-title":"Porphyrias: a 2015 update","volume":"39","author":"Karim","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B8","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1172\/JCI1909","article-title":"Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications","volume":"101","author":"D\u00f6ring","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1562\/0031-8655(2000)071<0640:AABNAA>2.0.CO;2","article-title":"5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters","volume":"71","author":"Rud","year":"2000","journal-title":"Photochem Photobiol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1152\/physrev.1998.78.4.969","article-title":"Molecular biology of mammalian plasma membrane amino acid transporters","volume":"78","author":"Palacin","year":"1998","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biochi.2014.08.014","article-title":"Pro-oxidant effect of ALA is implicated in mitochondrial dysfunction of HepG2 cells","volume":"106","author":"Laafi","year":"2014","journal-title":"Biochimie"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B12","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/ijd.13580","article-title":"Porphyria cutanea tarda: an intriguing genetic disease and marker","volume":"56","author":"Handler","year":"2017","journal-title":"Int J Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B13","first-page":"336","article-title":"Regulation of porphyrin and heme metabolism in the kidney","volume":"25","author":"Woods","year":"1988","journal-title":"Semin Hematol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: implications for kidney disease","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ki.1995.414","article-title":"Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat","volume":"48","author":"Agarwal","year":"1995","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0041-008X(80)90131-3","article-title":"Chronic low-level lead toxicity in the rat. III. An integrated assessment of long-term toxicity with special reference to the kidney","volume":"56","author":"Fowler","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0041-008X(78)90015-7","article-title":"Altered regulation of mammalian hepatic heme biosynthesis and urinary porphyrin excretion during prolonged exposure to sodium arsenate","volume":"43","author":"Woods","year":"1978","journal-title":"Toxicol Appl Pharmacol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B18","first-page":"266","article-title":"Renal porphyrinuria during chronic methyl mercury exposure","volume":"90","author":"Woods","year":"1977","journal-title":"J Lab Clin Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B19","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.bbapap.2010.12.015","article-title":"Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis","volume":"1814","author":"Hunter","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-8-8","article-title":"Recommendations for the management of tyrosinaemia type 1","volume":"8","author":"de Laet","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B21","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2000.105504","article-title":"Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review","volume":"42","author":"Shieh","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dth.12024","article-title":"Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure","volume":"27","author":"Vasconcelos","year":"2014","journal-title":"Dermatol Ther"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/1523-1747.ep12276482","article-title":"A porphyria cutanea tarda-like distribution pattern of porphyrins in plasma, hemodialysate, hemofiltrate, and urine of patients on chronic hemodialysis","volume":"85","author":"Seubert","year":"1985","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000181958","article-title":"Porphyrins in chronic renal failure","volume":"26","author":"Day","year":"1980","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000188584","article-title":"Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis","volume":"70","author":"Mamet","year":"1995","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000187193","article-title":"Porphyrin metabolism abnormalities and its treatment in a uremic patient with porphyria cutanea tarda","volume":"63","author":"Yasuda","year":"1993","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000185945","article-title":"Plasma porphyrins in chronic renal failure","volume":"55","author":"Gebril","year":"1990","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1681\/ASN.V291445","article-title":"Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease","volume":"2","author":"Carson","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0272-6386(95)90621-5","article-title":"Efficiency of three different hemodialysis membranes for plasma porphyrin removal","volume":"25","author":"Fontanellas","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Ryan Caballes","year":"2012","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B31","first-page":"73","article-title":"Iron, genes, and viruses: the porphyria cutanea tarda triple threat","volume":"88","author":"Van Meter","year":"2011","journal-title":"Cutis"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B32","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/oxfordjournals.ndt.a027669","article-title":"Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium","volume":"11","author":"Gafter","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJM199002013220507","article-title":"Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis","volume":"322","author":"Anderson","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0190-9622(08)82010-5","article-title":"Treatment of porphyria cutanea tarda of end-stage renal disease with erythropoietin","volume":"29","author":"Sarkell","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199703133361116","article-title":"Renal transplantation for porphyria cutanea tarda","volume":"336","author":"Ewing","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.1993.01680240077010","article-title":"Porphyria cutanea tarda in the setting of renal failure. Response to renal transplantation","volume":"129","author":"Stevens","year":"1993","journal-title":"Arch Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mjd.2000.111338","article-title":"Pseudoporphyria","volume":"44","author":"Green","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ki.2015.97","article-title":"High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria","volume":"88","author":"Pallet","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B39","first-page":"986","article-title":"Hypertension and renal impairment as complications of acute porphyria","volume":"7","author":"Church","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2796.1994.tb01279.x","article-title":"Hypertension and renal disease in patients with acute intermittent porphyria","volume":"236","author":"Andersson","year":"1994","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/clm.1997.15.83","article-title":"Pilot in vitro toxicity study of 5-ALA and Photofrin in microvascular endothelial cell cultures","volume":"15","author":"Chang","year":"1997","journal-title":"J Clin Laser Med Surg"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jphotobiol.2013.06.014","article-title":"Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall","volume":"126","author":"Middelburg","year":"2013","journal-title":"J Photochem Photobiol B"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2796.2000.00653.x","article-title":"Could attacks of abdominal pain in cases of acute intermittent porphyria be due to intestinal angina?","volume":"247","author":"Lithner","year":"2000","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B44","doi-asserted-by":"crossref","first-page":"598","DOI":"10.7326\/0003-4819-123-8-199510150-00006","article-title":"Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria","volume":"123","author":"Kupferschmidt","year":"1995","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archneur.1977.00500170064013","article-title":"Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination","volume":"34","author":"Lai","year":"1977","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00234-002-0823-x","article-title":"MRI reveals reversible lesions resembling posterior reversible encephalopathy in porphyria","volume":"44","author":"\u00c7elik","year":"2002","journal-title":"Neuroradiology"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/197140090802100508","article-title":"Reversible MRI findings of porphyric encephalopathy. A report of two cases","volume":"21","author":"Soysal","year":"2008","journal-title":"Neuroradiol J"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.V103507","article-title":"The intrarenal vascular lesions associated with primary antiphospholipid syndrome","volume":"10","author":"Nochy","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5414\/CNP69339","article-title":"Acute intermittent porphyria and chronic renal failure","volume":"69","author":"Marsden","year":"2008","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B50","first-page":"66","article-title":"Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapy regimes","volume":"55","author":"Sardh","year":"2009","journal-title":"Cell Mol Biol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B51","first-page":"271","article-title":"Renal transplantation for chronic renal failure in acute porphyria","volume":"2","author":"Nunez","year":"1987","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/00912700122009764","article-title":"The tolerability of newer immunosuppressive medications in a patient with acute intermittent porphyria","volume":"41","author":"Barone","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B53","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/ndt\/17.6.1147","article-title":"Sirolimus tolerability in a kidney transplant recipient with acute intermittent porphyria","volume":"17","author":"El-Haggan","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B54","first-page":"311","article-title":"[Acute intermittent porphyria and inappropriate ADH syndrome]","volume":"57","author":"Tebar","year":"2010","journal-title":"Rev Esp Anestesiol Reanim"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B55","first-page":"85","article-title":"[Porphyria and inappropriate antidiuretic hormone syndrome]","volume":"24","author":"Lopez Montes","year":"2004","journal-title":"Nefrologia"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B56","first-page":"418","article-title":"Severe hyponatremia due to SIADH provoked by acute intermittent porphyria","volume":"45","author":"Usalan","year":"1996","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20180626045844_sfx146-B57","doi-asserted-by":"crossref","first-page":"851","DOI":"10.7326\/0003-4819-83-6-851","article-title":"Acute intermittent porphyria: clinical and selected research aspects","volume":"83","author":"Tschudy","year":"1975","journal-title":"Ann Intern Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/11\/2\/191\/25084988\/sfx146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T22:46:47Z","timestamp":1660085207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/11\/2\/191\/4797539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":57,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,10]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfx146","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,1,10]]}}}